$MDXG
MIMEDX GROUP, INC. Stock $mdxg

$mdxg Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-Q Financial Statement

#000137633914000043 Filed on November 10, 2014

Income Statement

Concept	2014 Q4	2014 Q3	2013 Q4
Revenue	$39.57M	$33.52M	$17.99M
YoY Change	119.92%	107.98%	71.22%
Cost Of Revenue	$3.600M	$3.348M	$3.110M
YoY Change	15.76%	58.41%	84.02%
Gross Profit	$35.97M	$30.17M	$14.88M
YoY Change	141.71%	115.47%	68.74%
Gross Profit Margin	90.9%	90.01%	82.71%
Selling, General & Admin	$29.24M	$24.19M	$14.28M
YoY Change	104.76%	90.33%	75.21%
% of Gross Profit	81.28%	80.19%	95.95%
Research & Development	$1.850M	$2.014M	$1.380M
YoY Change	34.06%	56.44%	21.05%
% of Gross Profit	5.14%	6.68%	9.27%
Depreciation & Amortization	$570.0K	$313.0K	$480.0K
YoY Change	18.75%	69.19%	26.32%
% of Gross Profit	1.58%	1.04%	3.23%
Operating Expenses	$31.32M	$26.21M	$15.93M
YoY Change	96.61%	87.21%	62.72%
Operating Profit	$4.653M	$3.731M	-$1.047M
YoY Change	-544.41%	-1558.04%	7.94%
Interest Expense	-$10.00K	$9.126K	-$10.00K
YoY Change	0.0%	101.59%	-98.41%
% of Operating Profit	-0.21%	0.24%
Other Income/Expense, Net		-$9.000K
YoY Change
Pretax Income	$4.640M	$3.722M	-$1.420M
YoY Change	-426.76%	-1529.24%	-11.8%
Income Tax	$810.0K	$22.00K	$0.00
% Of Pretax Income	17.46%	0.59%
Net Earnings	$3.832M	$3.700M	-$1.427M
YoY Change	-368.54%	-1305.21%	-11.09%
Net Earnings / Revenue	9.68%	11.04%	-7.93%
Basic Earnings Per Share	$0.04	$0.03	-$0.01
Diluted Earnings Per Share	$0.03	$0.03	-$0.01
COMMON SHARES
Basic Shares Outstanding	106.9M shares	105.8M shares	97.85M shares
Diluted Shares Outstanding		112.8M shares

Balance Sheet

Concept	2014 Q4	2014 Q3	2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$52.30M	$47.30M	$44.10M
YoY Change	18.59%	675.41%	548.53%
Cash & Equivalents	$46.58M	$47.25M	$44.08M
Short-Term Investments	$5.800M
Other Short-Term Assets	$1.500M	$2.000M	$1.300M
YoY Change	15.38%	33.33%	85.71%
Inventory	$5.133M	$4.739M	$3.881M
Prepaid Expenses
Receivables	$26.67M	$23.30M	$16.09M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$85.68M	$77.26M	$65.39M
YoY Change	31.03%	198.94%	261.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.447M	$5.052M	$4.086M
YoY Change	33.31%	34.31%	281.29%
Goodwill	$4.040M	$4.040M	$4.040M
YoY Change	0.0%	0.0%	-0.01%
Intangibles	$10.85M	$10.96M	$11.18M
YoY Change	-2.99%	-5.91%	-6.15%
Long-Term Investments	$3.300M
YoY Change
Other Assets	$0.00		$0.00
YoY Change			-100.0%
Total Long-Term Assets	$23.58M	$20.05M	$19.31M
YoY Change	22.15%	3.1%	12.94%
TOTAL ASSETS
Total Short-Term Assets	$85.68M	$77.26M	$65.39M
Total Long-Term Assets	$23.58M	$20.05M	$19.31M
Total Assets	$109.3M	$97.32M	$84.69M
YoY Change	29.0%	114.85%	140.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.661M	$2.759M	$2.491M
YoY Change	47.0%	25.1%	98.97%
Accrued Expenses	$2.504M	$1.990M	$1.406M
YoY Change	78.09%	41.12%	41.92%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$18.40M	$14.45M	$9.608M
YoY Change	91.55%	73.43%	91.5%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$1.526M	$1.612M	$1.518M
YoY Change	0.53%	13.0%	329.62%
Total Long-Term Liabilities	$1.526M	$1.612M	$1.518M
YoY Change	0.53%	13.0%	-65.23%
TOTAL LIABILITIES
Total Short-Term Liabilities	$18.40M	$14.45M	$9.608M
Total Long-Term Liabilities	$1.526M	$1.612M	$1.518M
Total Liabilities	$19.93M	$16.06M	$11.13M
YoY Change	79.13%	64.6%	-26.68%
SHAREHOLDERS EQUITY
Retained Earnings	-$67.58M	-$71.41M	-$73.80M
YoY Change	-8.43%	-1.33%	5.9%
Common Stock	$108.0K	$107.8K	$104.0K
YoY Change	3.85%	10.39%	17.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$5.637M	$5.337M	$25.00K
YoY Change	22448.0%	21248.31%	0.0%
Treasury Stock Shares	986.6K shares	944.5K shares	50.00K shares
Shareholders Equity	$89.33M	$81.26M	$73.57M
YoY Change
Total Liabilities & Shareholders Equity	$109.3M	$97.32M	$84.69M
YoY Change	29.0%	114.85%	140.73%

Cashflow Statement

Concept	2014 Q4	2014 Q3	2013 Q4
OPERATING ACTIVITIES
Net Income	$3.832M	$3.700M	-$1.427M
YoY Change	-368.54%	-1305.21%	-11.09%
Depreciation, Depletion And Amortization	$570.0K	$313.0K	$480.0K
YoY Change	18.75%	69.19%	26.32%
Cash From Operating Activities	$8.280M	$8.950M	$830.0K
YoY Change	897.59%	417.34%	-195.4%
INVESTING ACTIVITIES
Capital Expenditures	-$840.0K	-$880.0K	-$500.0K
YoY Change	68.0%	-22.12%	108.33%
Acquisitions
YoY Change
Other Investing Activities	-$9.000M		$0.00
YoY Change
Cash From Investing Activities	-$9.840M	-$880.0K	-$500.0K
YoY Change	1868.0%	-22.12%	108.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	880.0K	-60.00K	37.66M
YoY Change	-97.66%	-104.69%	15591.67%
NET CHANGE
Cash From Operating Activities	8.280M	8.950M	830.0K
Cash From Investing Activities	-9.840M	-880.0K	-500.0K
Cash From Financing Activities	880.0K	-60.00K	37.66M
Net Change In Cash	-680.0K	8.010M	37.99M
YoY Change	-101.79%	326.06%	-4466.67%
FREE CASH FLOW
Cash From Operating Activities	$8.280M	$8.950M	$830.0K
Capital Expenditures	-$840.0K	-$880.0K	-$500.0K
Free Cash Flow	$9.120M	$9.830M	$1.330M
YoY Change	585.71%	243.71%	-311.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2490531	USD
CY2014Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2759409	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16092836	USD
CY2014Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	23304472	USD
CY2014Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1989997	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1405974	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2301870	USD
CY2014Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3166028	USD
CY2014Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	157893595	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	147284219	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8160678	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8160678	USD
CY2013Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1667766	USD
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3021962	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4155005	USD
CY2014Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1328439	USD
CY2013Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	789809	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	695368	USD
CY2014Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	232079	USD
CY2013Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	259575	USD
CY2014Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7057713	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7193672	shares
CY2013Q4	us-gaap	Assets Assets	84693893	USD
CY2014Q3	us-gaap	Assets Assets	97317407	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	65388771	USD
CY2014Q3	us-gaap	Assets Current AssetsCurrent	77264455	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	107259	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44077751	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	47253003	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6754485	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	630882	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	3175252	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-692729	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	584023	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	419462	USD
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	3859434	USD
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	1807143	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-41641	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	857914	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1510278	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6061756	USD
CY2014Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	130000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	130000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	104425614	shares
CY2014Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	107834036	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	104375614	shares
CY2014Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	106889570	shares
CY2014Q3	us-gaap	Common Stock Value CommonStockValue	107834	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	104426	USD
CY2014Q3	us-gaap	Contractual Obligation ContractualObligation	7208235	USD
CY2014Q3	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	478325	USD
CY2014Q3	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	1463054	USD
CY2014Q3	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	1879579	USD
CY2014Q3	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	1863354	USD
CY2014Q3	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	1523923	USD
CY2014Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	3348005	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	6216940	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	9065248	USD
CY2013Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2113438	USD
	us-gaap	Depreciation Depreciation	864158	USD
	us-gaap	Depreciation Depreciation	422524	USD
CY2014Q3	us-gaap	Depreciation Depreciation	313000	USD
CY2013Q3	us-gaap	Depreciation Depreciation	185000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-70000	USD
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0375
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0092
CY2014Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9448245	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5588811	USD
CY2014Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	16675914	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	6192323	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	232306	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	829626	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	839593	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	929226	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	929226	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9952300	USD
CY2014Q3	us-gaap	Goodwill Goodwill	4040443	USD
CY2013Q4	us-gaap	Goodwill Goodwill	4040443	USD
CY2013Q3	us-gaap	Gross Profit GrossProfit	14002270	USD
	us-gaap	Gross Profit GrossProfit	69584900	USD
	us-gaap	Gross Profit GrossProfit	34970003	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	30169757	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2409536	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3721767	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2587940	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-260418	USD
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	46700	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	22062	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	96975	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	22062	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	96967	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	80953	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	355269	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	954094	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6052963	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7211636	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	132302	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	311520	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	913644	USD
CY2013Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	14181897	USD
CY2014Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	14658992	USD
CY2014Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10960300	USD
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11178573	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	9126	USD
	us-gaap	Interest Expense InterestExpense	38579	USD
CY2013Q3	us-gaap	Interest Expense InterestExpense	4527	USD
	us-gaap	Interest Expense InterestExpense	32503	USD
	us-gaap	Interest Paid InterestPaid	38347	USD
	us-gaap	Interest Paid InterestPaid	22971	USD
CY2013Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1048886	USD
CY2014Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1664729	USD
CY2014Q3	us-gaap	Inventory Gross InventoryGross	5163445	USD
CY2013Q4	us-gaap	Inventory Gross InventoryGross	4203004	USD
CY2014Q3	us-gaap	Inventory Net InventoryNet	4738690	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	3880776	USD
CY2013Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	202414	USD
CY2014Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	270191	USD
CY2014Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	424755	USD
CY2013Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	322228	USD
CY2014Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	3228525	USD
CY2013Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2951704	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	762000	USD
CY2013Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	364000	USD
CY2014Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	282000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	847000	USD
	us-gaap	Lessee Leasing Arrangements Operating Leases Term Of Contract LesseeLeasingArrangementsOperatingLeasesTermOfContract	P5Y
CY2013Q4	us-gaap	Liabilities Liabilities	11125823	USD
CY2014Q3	us-gaap	Liabilities Liabilities	16061156	USD
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	97317407	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	84693893	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9607867	USD
CY2014Q3	us-gaap	Liabilities Current LiabilitiesCurrent	14449229	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3034884	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2966907	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2307356	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2534973	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8517492	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1124663	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-307118	USD
	us-gaap	Net Income Loss NetIncomeLoss	2387474	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2684915	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	3699705	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1226998	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-255891	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	3730893	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	2448115	USD
CY2013Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	122551	USD
CY2014Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	251578	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1517956	USD
CY2014Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1611927	USD
	us-gaap	Payments For Tenant Improvements PaymentsForTenantImprovements	0	USD
	us-gaap	Payments For Tenant Improvements PaymentsForTenantImprovements	996866	USD
	us-gaap	Payments To Acquire Equipment On Lease PaymentsToAcquireEquipmentOnLease	88522	USD
	us-gaap	Payments To Acquire Equipment On Lease PaymentsToAcquireEquipmentOnLease	29797	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	1830261	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	2008407	USD
CY2014Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1968290	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1337408	USD
	us-gaap	Proceeds From Repurchase Of Equity ProceedsFromRepurchaseOfEquity	-5312077	USD
	us-gaap	Proceeds From Repurchase Of Equity ProceedsFromRepurchaseOfEquity	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1497090	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1516580	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	868625	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1480124	USD
CY2014Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8218237	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6387976	USD
CY2014Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5052209	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4086106	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5204153	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3458585	USD
CY2013Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1287361	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2014306	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-73795575	USD
CY2014Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-71408101	USD
	us-gaap	Revenue Recognition Sales Of Goods RevenueRecognitionSalesOfGoods	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company sells its products through a combination of a direct sales force and independent stocking distributors and representatives in the U.S. and independent distributors in international markets. The Company recognizes revenue when title to the goods transfers to customers, provided there are no material remaining performance obligations required of the Company or any matters of customer acceptance. In cases where the Company utilizes distributors or ships product directly to the end user, it recognizes revenue upon shipment provided all revenue recognition criteria have been met. A portion of the Company's revenue is generated from inventory maintained at hospitals or with the field representatives. For these products, revenue is recognized at the time the product has been used or implanted. The Company records estimated sales returns, discounts and allowances as a reduction of net sales in the same period revenue is recognized.  </font></div></div>
CY2013Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	16115708	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	41186943	USD
CY2014Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	33517762	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	78650148	USD
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.87
CY2013Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12711225	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	8160678	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	4155005	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.645
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.6456
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	6517614	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	249670	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.04
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2948969	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.09
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	64630326	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15375960	shares
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24192479	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	31948607	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	61237264	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.6141
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.636
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0188
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0196
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0085
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0169
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	16515621	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	16843940	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.32
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.46
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	64242362	USD
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	8987368	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.03
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	3.27
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.31
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.81
CY2014Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	8987368	shares
CY2014Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	16843940	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2014Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	47252742	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y8M12D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y6M
CY2014Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	1.87
CY2014Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	3.32
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y6M
	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	5272004	shares
	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	0	shares
	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	13158	shares
	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	0	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1146987	shares
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	5272004	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	86391	USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	0	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1497090	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	5312077	USD
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	81256251	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	73568070	USD
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	50000	shares
CY2014Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	944466	shares
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	25000	USD
CY2014Q3	us-gaap	Treasury Stock Value TreasuryStockValue	5337077	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. </font></div></div>
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	7193672	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2013Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2014Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	7057713	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	112525016	shares
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	112814658	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95429988	shares
CY2013Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	96914856	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105756945	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105331344	shares
CY2013Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	96914856	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95429988	shares
CY2014Q3	mdxg	Capital Leases Interest Rate Effective Percentage Maximum CapitalLeasesInterestRateEffectivePercentageMaximum	0.12
CY2014Q3	mdxg	Capital Leases Interest Rate Effective Percentage Minimum CapitalLeasesInterestRateEffectivePercentageMinimum	0.03
CY2013Q4	mdxg	Intangible Assets Accumulated Amortization And Impairment Charges IntangibleAssetsAccumulatedAmortizationAndImpairmentCharges	3003324	USD
CY2014Q3	mdxg	Intangible Assets Accumulated Amortization And Impairment Charges IntangibleAssetsAccumulatedAmortizationAndImpairmentCharges	3698692	USD
	mdxg	Number Of Share Based Compensation Plans NumberOfShareBasedCompensationPlans	3	plan
	mdxg	Numberof Patients NumberofPatients	150	patient
CY2014Q3	mdxg	Outstanding Assumed Options OutstandingAssumedOptions	375000	shares
	mdxg	Paymentsfor Application Costs Patent PaymentsforApplicationCostsPatent	526566	USD
	mdxg	Paymentsfor Application Costs Patent PaymentsforApplicationCostsPatent	477095	USD
	mdxg	Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Outstanding Vested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsOutstandingVestedNumber	84332	shares
	mdxg	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	868625	USD
	mdxg	Warrants Term WarrantsTerm	P5Y
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Period End Date DocumentPeriodEndDate	2014-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001376339
CY2014Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	106938400	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	MIMEDX GROUP, INC.

Files In Submission

Name	View Source	Status
0001376339-14-000043-index-headers.html	Edgar Link	pending
0001376339-14-000043-index.html	Edgar Link	pending
0001376339-14-000043.txt	Edgar Link	pending
0001376339-14-000043-xbrl.zip	Edgar Link	pending
exhibit311-certificationof.htm	Edgar Link	pending
exhibit312-certificationof.htm	Edgar Link	pending
exhibit321-certificationof.htm	Edgar Link	pending
exhibit322-certificationof.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
mdxg-20140930.xml	Edgar Link	completed
mdxg-20140930.xsd	Edgar Link	pending
mdxg-20140930_cal.xml	Edgar Link	unprocessable
mdxg-20140930_def.xml	Edgar Link	unprocessable
mdxg-20140930_lab.xml	Edgar Link	unprocessable
mdxg-20140930_pre.xml	Edgar Link	unprocessable
mdxg-2014930x10xq.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MDXG
MIMEDX GROUP, INC. Stock $mdxg

2014 Q4 Form 10-Q Financial Statement

#000137633914000043 Filed on November 10, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDXG MIMEDX GROUP, INC. Stock $mdxg

2014 Q4 Form 10-Q Financial Statement

#000137633914000043 Filed on November 10, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDXG
MIMEDX GROUP, INC. Stock $mdxg